什么时候以及如何在骨髓纤维化中移植 - 最近的趋势
Naman Sharma1, Giuseppe G Loscocco2,3, Naseema Gangat2
1Department of Hematology and Oncology, University of Massachusetts-Baystate Medical Center, Springfield, MA, USA.
Leukemia & lymphoma
|November 14, 2024
概括
全基性造血干细胞移植 (AHSCT) 提供了治疗髓纤维化 (MF) 的方法. 尽管结果有所改善,但像GVHD这样的风险仍然存在,但替代捐赠者现在更安全,扩大了MF患者的获取.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 全基性造血干细胞移植 (AHSCT) 是髓纤维化 (MF) 的唯一治愈治疗方法.
- 在HLA类型,调节和支持性护理方面的重大进展改善了AHSCT的结果.
- 然而,接受AHSCT的MF患者面临相当大的风险,包括毒性,移植失败,感染和移植与宿主疾病 (GVHD).
研究的目的:
- 审查当前针对骨髓纤维化风险分层策略.
- 突出用于AHSCT患者选择的实用算法.
- 讨论AHSCT在管理中等风险和高风险MF中的不断变化的作用.
主要方法:
- 关于骨髓纤维化AHSCT最近文献的综述.
- 分析GVHD预防和替代性供体移植方面的进展.
- 评估包括临床和遗传因素的当代预后模型.
主要成果:
- AHSCT仍然是髓纤维化病的唯一治愈选择.
- 移植后的环胺改善了替代性供体移植的安全性和可行性.
- 当代风险分层模型对于指导治疗决策至关重要,包括AHSCT时间.
结论:
- 所有患有中期或高风险骨髓纤维化症的患者应对AHSCT进行评估.
- 早期考虑AHSCT与延迟策略是必不可少的.
- 使用验证的预后模型进行个性化风险评估是最佳患者管理的关键.
相关概念视频
Bone Marrow Sampling and Transplants
286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341


